dpp4 with glp 1 degrade the GLP1 and incretion, which leads to suppression of the DPP-4 inhibitors and GLP-1RAs: cardiovascular
Description
It relaxes blood vessels, improves circulation, and helps regulate blood pressure
A spokesperson for Novo Nordisk UK, which manufactures Ozempic and Wegovy, said: Patient safety is of the utmost importance to Novo Nordisk
While individual case reports of various cancers have been submitted, these reports do not establish causation, as patients taking these medications have multiple risk factors for cancer, including obesity, diabetes, and age
3.3 Improved tools for mechanistic validation and risk de-risking Technological advances have also improved the ability to de-risk peptide systems earlier in development
